|
Focused Ultrasound Treatment
In 2004, the Food and Drug Administration approved a device called ExAblate 2000, which uses MRI-guided ultrasound to target and destroy fibroids. It's intended only for premenopausal women who have completed childbearing. Unlike any other treatment, other than the use of medications, focused ultrasound is completely noninvasive. The therapy focuses ultrasound energy to destroy the fibroid tissue. The technique is very accurate, given that a real-time MRI is performed during the procedure to map out and confirm that the ultrasound waves are targeting the fibroid precisely.
Because this treatment is still being investigated for long-term outcomes, insurers may not cover it.
|